ACDM News Item

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

Date: April 22, 2026

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent publications from the UK Medicines and Healthcare products Regulatory Agency (MHRA) including the release of new guidelines, updates to the Inspection Dossier templates and annotations to ICH E6 (R3) and ICH E8 (R1). These guidelines go into effect on April 28, 2026.

To assist data managers in complying with the new guidelines, the DMEG is releasing a summary of the highlights which impact data managers including:

o AI/ML documentation for Data Management
o Clinical trial record archiving and retention
o Data protection and subject rights

View the paper here
The Regulatory Considerations DMEG will continue to review MHRA guidance as they are published, and an upcoming review will be on the Guidance on quality and risk proportionality (published 27 March 2026). In the interim, you can access that document at the MHRA Clinical Trial Hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-guidance-on-quality-and-risk-proportionality

Explore More News

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .

Welcome CROss Alliance as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance . . .

Regulatory Considerations DMEG Update

With mixed feelings, we share that Silvia Pérez Torres, current chair of the ACDM . . .

Newsletter Committee’s Christmas Copilot Tips

In a time when we are constantly surrounded by artificial intelligence and feel the need . . .

Welcome Data Magik as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Data Magik as . . .

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .